Company intelligence / Profile preview

IFG Fund

New York City, New York, United States

Ownership: Private
Employees: ~26
Development stage: Other

Overview

IFG Fund appears to be a private financial services firm, not a life sciences, biotech, pharma, or healthcare operating company. Available public references describe it as a hedge fund or pooled investment vehicle based in New York City and founded around 2020. The firm seems focused on long-short equity or related investment strategies rather than drug development, medical products, or healthcare services. As a result, it does not appear to have a therapeutic pipeline, clinical stage, or health-related platform technology.

Industry: Investors

Beyond the preview

Go deeper on IFG Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IFG Fund.

Explore the full profile